Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.43 M9.34 M1.09 M974.58 K 12.84 M Research & development ———— — Operating income -1.63 M-9.54 M-1.35 M-978.97 K -13.51 M Non-Operating Income, Total -6.86 M-341.37 K-1.34 M— — Interest expense, net of interest capitalized 625.05 K320.01 K940.86 K889.45 K 2.78 M Non-Operating Income, excl. Interest Expenses -625.05 K-320.01 K-940.86 K— — Unusual income/expense -6.86 M-341.37 K-1.34 M— — Pretax income -1.15 M-9.39 M-1.37 M-1.24 M -13.15 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense 04 300—— — Net income before discontinued operations -8.49 M-9.89 M-3.21 M-2.14 M -23.72 M Discontinued operations ———0 — Net income -8.49 M-9.89 M-3.21 M-2.14 M -23.72 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -8.49 M-9.89 M-3.21 M-2.51 M -24.1 M Basic earnings per share (Basic EPS) -17.88-18.04-3.28-1.88 -41.08 Diluted earnings per share (Diluted EPS) -17.88-18.04-3.28-1.88 -41.08 Average basic shares outstanding 474.97 K547.88 K544.6 K1.14 M — Diluted shares outstanding 474.97 K547.88 K544.6 K1.14 M — EBITDA -1.9 M-9.53 M249.34 K-960.83 K -12.15 M EBIT -1.26 M-9.54 M-1.71 M-976.59 K -13.49 M Cost of revenue 00—— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) -637.94 K11.36 K1.64 M15.77 K 1.03 M